Submitted on July 9, 2004
Revised on November 17, 2004
Accepted on November 18, 2004
Levels of 7-oxocholesterol in cerebrospinal fluid in patients with multiple sclerosis are more than a thousand times lower than reported
Valerio Leoni, Dieter Lütjohann, and Thomas Masterman
Department of Clinical Pharmacology, University of Bonn, Bonn 53105
Corresponding Author: dieter.luetjohann{at}ukb.uni-bonn.de
In a recent publication by Diestel et al. extremely high levels of 7-oxocholesterol were reported in cerebrospinal fluid of eleven patients with multiple sclerosis to be 7.4 +/- 0.3 mg/L (mean +/- SEM). The corresponding levels of 12 subjects with other kinds of neurological diseases were reported to be 0.5 +/- 0.1 mg/L. Such high levels of 7-oxocholesterol were found to cause neuronal damage of living brain tissues. Using a highly accurate method for an assay of 7-oxocholesterol based on isotope dilution-mass spectrometry and anaerobic conditions during work up, we found that the levels of 7-oxocholesterol in cerebrospinal fluid from 29 Swedish patients with multiple sclerosis were only 1.2 µg/L (median, ranging from 0.4 to 4.6 µg/L), less than 1/1000 of the previously reported levels. The levels of 7-oxocholesterol in cerebrospinal fluid from 24 Swedish control patients were 0.9 µg/L (0.3 – 2.3 µg/L), slightly, but significantly lower than the cerebrospinal fluid levels in multiple sclerosis patients (p = 0.002). In vitro induced lipid peroxidation of the endogenous cholesterol in cerebrospinal fluid increased the levels of 7-oxygenated cholesterol metabolites, particularly 7-oxocholesterol, up to about 0.3 mg/L. The results are discussed in relation to the fact that 7-oxygenated steroids are easily artificially formed by autoxidation of cholesterol during work up procedure and analysis of sterols and oxysterols from biological samples.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
